Solace Therapeutics
Prior to his role as Vice President of Clinical Affairs, he spent 15 years at Health Policy Associates, Inc. a boutique consulting firm serving the medical device and biotechnology industry. At Health Policy Associates, Josh gained extensive experience in clinical development, working with dozens of small medical device companies to help them meet goals and milestones to obtain and keep necessary investment. During his last two years, he was the VP of the company helping several clients gain critical regulatory approvals that served as major inflection points for their continued growth.
This person is not in any offices
Solace Therapeutics
Solace Therapeutics is an emerging medical device company focused on the development of non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), Solace is dedicated to improving the patient’s quality of life by eliminating side effects typically associated with current drug and surgical therapies.